Correspondence 0001493152-24-052452 from Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc.
Date: Dec. 30, 2024 · CIK: 0001857044 · Accession: 0001493152-24-052452
AI Filing Summary & Sentiment
File numbers found in text: 333-284026
Show Raw Text
CORRESP
1
filename1.htm
Indaptus
Therapeutics, Inc.
3
Columbus Circle
15th
Floor
New
York, NY 10019
December
30, 2024
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
Indaptus
Therapeutics, Inc. (CIK 0001857044)
Registration
Statement No. 333-284026 on Form S-1 (the “Registration Statement”)
Ladies
and Gentlemen:
Indaptus
Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration
Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may
become effective on December 31, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, LLP, by calling Gary Emmanuel at +1-212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw
this request for acceleration.
Very
truly yours,
Indaptus
Therapeutics, Inc.
By:
/s/
Nir Sassi
Nir
Sassi
Chief
Financial Officer